HLB, Affiliates Raise HLB Therapeutics Stake to 20.14% From 20.05%

• HLB and related parties increased their disclosed holding in HLB Therapeutics to 20.14% from 20.05% as of October 21, 2026.
• Total holdings rose by 80,256 to 19,388,637 shares and share equivalents, reflecting market purchases and convertible bond conversion-price adjustments.
• Voting shares held increased to 18.78% from 18.7%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HLB Therapeutics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261021000048), on October 21, 2026, and is solely responsible for the information contained therein.